Origin of complex behaviour of spatially discordant alternans in a transgenic rabbit model of type 2 long QT syndrome.
Enhanced dispersion of repolarization has been proposed as an important mechanism in long QT related arrhythmias. Dispersion can be dynamic and can be augmented with the occurrence of spatially out-of-phase action potential duration (APD) alternans (discordant alternans; DA). We investigated the role of tissue heterogeneity in generating DA using a novel transgenic rabbit model of type 2 long QT syndrome (LQT2). Littermate control (LMC) and LQT2 rabbit hearts (n = 5 for each) were retrogradely perfused and action potentials were mapped from the epicardial surface using di-4-ANEPPS and a high speed CMOS camera. Spatial dispersion (Delta APD and Delta slope of APD restitution) were both increased in LQT2 compared to LMC (Delta APD: 34 +/- 7 ms vs. 23 +/- 6 ms; Delta slope: 1.14 +/- 0.23 vs. 0.59 +/- 0.19). Onset of DA under a ramp stimulation protocol was seen at longer pacing cycle length (CL) in LQT2 compared to LMC hearts (206 +/- 24 ms vs. 156 +/- 5 ms). Nodal lines between regions with APD alternans out of phase from each other were correlated with conduction velocity (CV) alternation in LMC but not in LQT2 hearts. In LQT2 hearts, larger APD dispersion was associated with onset of DA at longer pacing CL. At shorter CLs, closer to ventricular fibrillation induction (VF), nodal lines in LQT2 (n = 2 out of 5) showed persistent complex beat-to-beat changes in nodal line formation of DA associated with competing contribution from CV restitution and tissue spatial heterogeneity, increasing vulnerability to conduction block. In conclusion, tissue heterogeneity plays a significant role in providing substrate for ventricular arrhythmia in LQT2 rabbits by facilitating DA onset and contributing to unstable nodal lines prone to reentry formation.
Ziv
Ohad
O
Cardiovascular Research Center, Division of Cardiology, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
Morales
Eduardo
E
Song
Yoon-kyu
YK
Peng
Xuwen
X
Odening
Katja E
KE
Buxton
Alfred E
AE
Karma
Alain
A
Koren
Gideon
G
Choi
Bum-Rak
BR
D000200:Action Potentials; D000465:Algorithms; D000818:Animals; D030801:Animals, Genetically Modified; D004195:Disease Models, Animal; D000072237:ERG1 Potassium Channel; D004569:Electroencephalography; D055724:Electrophysiological Phenomena; D056149:Epicardial Mapping; D051638:Ether-A-Go-Go Potassium Channels / Q000235:genetics; D066298:In Vitro Techniques; D029593:Jervell-Lange Nielsen Syndrome / Q000235:genetics / Q000503:physiopathology; D008133:Long QT Syndrome / Q000145:classification / Q000235:genetics / Q000503:physiopathology*; D008297:Male; D008955:Models, Cardiovascular; D011817:Rabbits; D011994:Recombinant Proteins / Q000235:genetics
D000072237:ERG1 Potassium Channel; D051638:Ether-A-Go-Go Potassium Channels; D011994:Recombinant Proteins
Biophys J. 2006 Nov 15;91(10):3959-60
16935958
J Am Coll Cardiol. 2005 Jul 5;46(1):75-82
15992639
J Clin Invest. 2008 Jun;118(6):2246-59
18464931
Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2264-72
18835916
J Electrocardiol. 2001;34 Suppl:177-81
11781953
J Cardiovasc Electrophysiol. 2005 Sep;16(9):981-7
16174020
Heart Rhythm. 2007 May;4(5):619-26
17467631
Heart Rhythm. 2006 Jun;3(6):711-9
16731476
J Cardiovasc Electrophysiol. 2001 Feb;12(2):196-206
11232619
Heart Rhythm. 2009 Feb;6(2):251-9
19187920
Circulation. 1999 Mar 16;99(10):1385-94
10077525
J Cardiovasc Electrophysiol. 2003 Jun;14(6):632-8
12875425
J Am Coll Cardiol. 2008 May 27;51(21):2075-81
18498966
Circ Res. 2005 Mar 4;96(4):459-66
15662034
J Physiol. 1974 Aug;240(3):703-24
4415790
Circ Res. 2004 Apr 30;94(8):1083-90
15016735
Arch Mal Coeur Vaiss. 1966 Feb;59(2):263-72
4956181
J Physiol. 2007 Jan 1;578(Pt 1):115-29
17110412
Trends Cardiovasc Med. 2008 Aug;18(6):216-24
19185812
J Electrocardiol. 1999;32 Suppl:177-84
10688323
J Am Coll Cardiol. 2006 Jan 17;47(2):269-81
16412847
Am Heart J. 1975 Mar;89(3):378-90
234667
J Electrocardiol. 2007 Nov-Dec;40(6 Suppl):S70-4
17993333
J Cardiovasc Electrophysiol. 2004 Mar;15(3):323-31
15030424
Biophys J. 2007 Nov 15;93(10):3714-26
17978166
J Am Coll Cardiol. 2005 Sep 20;46(6):1067-75
16168293
Europace. 2007 Sep;9 Suppl 4:iv4-15
17766323
Biophys J. 2007 Jan 15;92(2):448-60
17071663
J Physiol. 2002 Sep 1;543(Pt 2):615-31
12205194
Biophys J. 2003 Dec;85(6):4134-45
14645100
Age Ageing. 1980 May;9(2):112-6
6104916
Arq Bras Cardiol. 2000 Aug;75(2):115-24
10983028
Crit Rev Clin Lab Sci. 2003 Jun;40(3):337-75
12892319
Exp Physiol. 2006 Mar;91(2):339-54
16452121
Am J Physiol Regul Integr Comp Physiol. 2002 Mar;282(3):R649-57
11832383
J Physiol. 2009 Feb 15;587(Pt 4):713-9
19218620
J Am Coll Cardiol. 2007 Jan 23;49(3):329-37
17239714
Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H327-35
16428336
Am J Physiol. 1967 Jun;212(6):1515-8
4952142
Europace. 2007 Nov;9 Suppl 6:vi77-82
17959697
Heart Rhythm. 2007 Aug;4(8):1057-68
17675081
Biophys J. 2007 Feb 15;92(4):L33-5
17172300
Cardiovasc Res. 1994 Oct;28(10):1547-54
8001044
Circulation. 2008 Jul 1;118(1):17-25
18559701
Circ Res. 2003 Apr 4;92(6):668-75
12600876
J Cardiovasc Electrophysiol. 2002 Nov;13(11):1141-9
12475106
Circulation. 2000 Oct 3;102(14):1664-70
11015345
J Intern Med. 2006 Jan;259(1):39-47
16336512
J Am Coll Cardiol. 1994 Jun;23(7):1541-6
8195511
Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H764-74
18055526
Cardiovasc Res. 1999 Jul;43(1):135-47
10536698
J Mol Cell Cardiol. 2008 Apr;44(4):633-46
18336833
Circ Res. 2000 Mar 3;86(4):396-407
10700444
Pacing Clin Electrophysiol. 1999 Jan;22(1 Pt 1):91-110
9990606
Am Heart J. 1975 Jan;89(1):45-50
1109551
Circ Res. 2006 May 26;98(10):1244-53
16728670
J Electrocardiol. 2007 Nov-Dec;40(6 Suppl):S75-80
17993334
Pacing Clin Electrophysiol. 2003 Aug;26(8):1660-7
12877697
Circulation. 1994 Sep;90(3):1469-80
8087954
Lancet. 2008 Aug 30;372(9640):750-63
18761222